🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized dose-ranging study will evaluate the safety, tolerability, ...
Status
Unknown
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01520116
This study will evaluate the efficacy and safety of bimatoprost sustained-r...
Status
Completed
Location
Eye Center South
Start Date
2014-12-15
Trial ID
NCT02250651
The purpose of the study is to evaluate the safety and effectiveness of an ...
Status
Completed
Location
Multiple Locations
Start Date
2004-07
Trial ID
NCT00293800
The purpose of this study is to evaluate the additive intraocular pressure ...
Status
Terminated
Location
Contact Alcon for Locations (Europe, Asia, and Latin America)
Start Date
2016-06-24
Trial ID
NCT02730871
This study will evaluate the efficacy and safety of bimatoprost SR in parti...
Status
Completed
Location
Arizona Glaucoma Specialists
Start Date
2014-12-15
Trial ID
NCT02247804
This is an exploratory study that will evaluate the safety and pharmacodyna...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01215786
To evaluate the safety and IOP lowering efficacy of OTX-TP, a sustained rel...
Status
Completed
Location
Vold Vision
Start Date
2014-11
Trial ID
NCT02312544
The purpose of the study is to evaluate the safety and effectiveness of an ...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00293787
The purpose of this study is to assess the IOP-lowering efficacy of a combi...
Status
Completed
Location
Western Eye Hospital
Start Date
2008-09
Trial ID
NCT00759239
Treatments Being Tested
Both Cosopt® and Xalatan® plus Timoptic® will significantly lower IOP, howe...
Status
Withdrawn
Location
Meir Medical Center
Start Date
2008-12
Trial ID
NCT00815373
Treatments Being Tested